Serum thyroglobulin improves the sensitivity of the McGill Thyroid nodule score for well-differentiated thyroid cancer

Thyroid

Volumn 24, Issue 5, 2014, Pages 852-857

  Scheffler, Patrick ^a   Forest, Veronique I ^a   Leboeuf, Rebecca ^b   Florea, Anca V ^a   Tamilia, Michael ^a   Sands, Noah B ^a   Hier, Michael P ^a   Mlynarek, Alexander M ^a   Payne, Richard J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; TUMOR MARKER;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER PATIENT; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIATED THYROID CANCER; FALSE NEGATIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MCGILL THYROID NODULE SCORE; MEDULLARY CARCINOMA; PAPILLARY CARCINOMA; PAPILLARY MICROCARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; THYROGLOBULIN BLOOD LEVEL; THYROID NODULE; THYROIDECTOMY; BLOOD; CANADA; CELL TRANSFORMATION; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; UNIVERSITY HOSPITAL; UPREGULATION;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUEBEC; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84901260396     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0191     Document Type: Article

References (20)

1. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nose V, Marqusee E, Larsen PR, Alexander EK 2007 Long-Term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111:508-516. (Pubitemid 350304903)
2. Hayat MJ, Howlader N, Reichman ME, Edwards BK 2007 Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20-37. (Pubitemid 46143500)
3. Brander A, Viikinkoski P, Tuuhea J, Voutilainen L, Kivisaari L 1992 Clinical versus ultrasound examination of the thyroid gland in common clinical practice. J Clin Ultrasound 20:37-42.
4. Liao S, Shindo M 2012 Management of well-differentiated thyroid cancer. Otolaryngol Clin North Am 45:1163-1179.
5. Zaydfudim V, Feurer ID, Griffin MR, Phay JE 2008 The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070-1077; discussion 1077-1078.
6. Sands NB, Karls S, Amir A, Tamilia M, Gologan O, Rochon L, Black MJ, Hier MP, Payne RJ 2011 McGill Thyroid Nodule Score (MTNS): ''rating the risk,'' a novel predictive scheme for cancer risk determination. J Otolaryngol Head Neck Surg 40:S1-S13.
7. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814. (Pubitemid 351398557)
8. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH 2008 Benign and malignant thyroid nodules: US differentiation- multicenter retrospective study. Radiology 247:762-770.
9. Koike E, Noguchi S, Yamashita H, Murakami T, Ohshima A, Kawamoto H 2001 Ultrasonographic characteristics of thyroid nodules: Prediction of malignancy. Arch Surg 136:334-337. (Pubitemid 32204972)
10. Tuttle RM, Lemar H, Burch HB 1998 Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377-383. (Pubitemid 28252418)
11. Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, Groshen S, Singer P, Lopresti J, Martin SE 2000 Follicular lesions of thyroid: A 5-year fine-needle aspiration experience. Cancer 90:335-341. (Pubitemid 32011844)
12. Sands NB, Karls S, Rivera J, Tamilia M, Hier MP, Black MJ, Gologan O, Payne RJ 2010 Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer. J Otolaryngol Head Neck Surg 39:669-673.
13. Hocevar M, Auersperg M 1998 Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours. Eur J Surg Oncol 24:553-557. (Pubitemid 28566903)
14. Ardito G, Revelli L, Giustozzi E, Salvatori M, Fadda G, Ardito F, Avenia N, Ferretti A, Rampin L, Chondrogiannis S, Colletti PM, Rubello D 2013 Aggressive papillary thyroid microcarcinoma: Prognostic factors and therapeutic strategy. Clin Nucl Med 38:25-28.
15. Lee EK, Chung KW, Min HS, Kim TS, Kim TH, Ryu JS, Jung YS, Kim SK, Lee YJ 2012 Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci 27:1014-1018.
16. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN 2011 Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390-3397.
17. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR 2012 Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. New Engl J Med 367:705-715.
18. Giovanella L, Ceriani L, Ghelfo A, Maffioli M, Keller F 2007 Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: Incidence, causes and management strategy. Clin Endocrinol 67:547-551. (Pubitemid 47416312)
19. Giovanella L, Suriano S, Ceriani L, Verburg FA 2011 Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan. Clin Nucl Med 36: 109-112.
20. Verburg FA, Wäschle K, Reiners C, Giovanella L, Lentjes EG 2010 Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res 42:736-739.